BS194 Inhibitor

MBS5758588 is an inhibitor targeting BS194. BS194 is as a potent cyclin-dependent protein kinases (CDKs) inhibitor.

Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach[J]. Journal of Molecular Recognition, 2012, 25(10):504-512.
Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach[J]. Journal of Molecular Recognition, 2012, 25(10):504-512.
Heathcote D A, Patel H, Kroll S H, et al. A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration.[J]. Journal of Medicinal Chemistry, 2010, 53(24):8508-8522.
Heathcote D A, Patel H, Kroll S H, et al. A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration.[J]. Journal of Medicinal Chemistry, 2010, 53(24):8508-8522.

Small volumes of BS194, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.